Mesothelin-Associated Anti-Senescence Through P53 in Pancreatic Ductal AdenocarcinomaDongliang Liu(Baylor College of Medicine), Qizhi Yao(Baylor College of Medicine)CancersJune 19, 202510.3390/cancers17122058Cited by 0SaveCiteExport RISWatch citationsRelated PapersMesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression|Molecular Cancer|2011|146Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib|PLoS ONE|2019|10